Version 1
: Received: 3 April 2024 / Approved: 3 April 2024 / Online: 4 April 2024 (17:50:33 CEST)
How to cite:
Cucerea, M.; Moscalu, M.; Ognean, M.; Fagarasan, A.; Toma, D.; Marian, R.; Anciuc-Crauciuc, M.; Racean, A.; Gall, Z.; Simon, M. Impact of Early Surfactant Administration on Ductus Arteriosus Assessed at 24 Hours in Preterm Neonates Less than 32 Weeks of Gestational Age. Preprints2024, 2024040351. https://doi.org/10.20944/preprints202404.0351.v1
Cucerea, M.; Moscalu, M.; Ognean, M.; Fagarasan, A.; Toma, D.; Marian, R.; Anciuc-Crauciuc, M.; Racean, A.; Gall, Z.; Simon, M. Impact of Early Surfactant Administration on Ductus Arteriosus Assessed at 24 Hours in Preterm Neonates Less than 32 Weeks of Gestational Age. Preprints 2024, 2024040351. https://doi.org/10.20944/preprints202404.0351.v1
Cucerea, M.; Moscalu, M.; Ognean, M.; Fagarasan, A.; Toma, D.; Marian, R.; Anciuc-Crauciuc, M.; Racean, A.; Gall, Z.; Simon, M. Impact of Early Surfactant Administration on Ductus Arteriosus Assessed at 24 Hours in Preterm Neonates Less than 32 Weeks of Gestational Age. Preprints2024, 2024040351. https://doi.org/10.20944/preprints202404.0351.v1
APA Style
Cucerea, M., Moscalu, M., Ognean, M., Fagarasan, A., Toma, D., Marian, R., Anciuc-Crauciuc, M., Racean, A., Gall, Z., & Simon, M. (2024). Impact of Early Surfactant Administration on Ductus Arteriosus Assessed at 24 Hours in Preterm Neonates Less than 32 Weeks of Gestational Age. Preprints. https://doi.org/10.20944/preprints202404.0351.v1
Chicago/Turabian Style
Cucerea, M., Zsuzsanna Gall and Marta Simon. 2024 "Impact of Early Surfactant Administration on Ductus Arteriosus Assessed at 24 Hours in Preterm Neonates Less than 32 Weeks of Gestational Age" Preprints. https://doi.org/10.20944/preprints202404.0351.v1
Abstract
Background and Objectives: The purpose of this study was to investigate whether early surfactant administration affects the status of ductus arteriosus (DA) in preterm infants ≤32 weeks of gestational age (GA) within 24 hours of birth. Materials and Methods: It is a prospective study conducted from March 15, 2022, to November 15, 2023, in a tertiary academic center. In-born infants ≤ 32 weeks of gestation (n = 88) were enrolled. The study group was further divided into surfactant (n=44) and non-surfactant (n=44) subgroups. Results: 76% of the preterm infants who received surfactant therapy (RRR = 0.839) recorded an increase in Kindler Score at 24 hours of life (1-RR = 1-0.24 = 76%). Surfactant administration was significantly associated with decreased pre-ductal diastolic pressure (29.9 mmHg vs. 34.8 mmHg, p=0.0231), post-ductal diastolic pressure (28.7 mmHg vs. 32.2 mmHg, p=0.0178) pre-ductal MAP (41.6 mmHg vs. 46.5 mmHg, p=0.0210) post-ductal MAP (41.0 mmHg vs. 45.3 mmHg, p=0.0336). There were no significant changes in ductus arteriosus parameters at 24 hours of life. Conclusions: Early surfactant administration does not affect the status of ductus arteriosus in preterm infants ≤32 weeks of gestational age at 24 hours of life.
Medicine and Pharmacology, Pediatrics, Perinatology and Child Health
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.